The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Open accessAbstract
Immunoassays have made it possible to measure dozens of individual proteins and other analytes in human samples for help in establishing the diagnosis and prognosis of disease. In too many cases the results of those measurements are misleading and can lead to unnecessary treatment or missed opportunities for therapeutic interventions. These cases stem from problems inherent to immunoassays performed with human samples, which include a lack of concordance across platforms, autoantibodies, anti-reagent antibodies, and the high-dose hook effect. Tandem mass spectrometry may represent a detection method capable of alleviating many of the flaws inherent to immunoassays. We review our understanding of the problems associated with immunoassays on human specimens and describe methodologies using tandem mass spectrometry that could solve some of those problems. We also provide a critical discussion of the potential pitfalls of novel mass spectrometric approaches in the clinical laboratory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Ion Suppression in Mass Spectrometry
Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,591
Electrospray interface for liquid chromatographs and mass spectrometers
Whitehouse, C. M., Dreyer, R. N., Yamashita, M., & Fenn, J. B. (1985) · Analytical Chemistry · doi:10.1021/ac00280a023 · Cited by 1,512
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
Anderson, L., & Hunter, C. L. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500331-mcp200 · Cited by 1,230
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004) · Journal of Proteome Research · doi:10.1021/pr034086h · Cited by 804
Mass spectrometry for proteomics
Han, X., Aslanian, A., & Yates, J. R. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.07.024 · Cited by 734
Siva, N. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-256b · Cited by 622
Human Anti-Animal Antibody Interferences in Immunological Assays
Kricka, L. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.942 · Cited by 586
IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MAN
YALOW, R. S., & BERSON, S. A. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00274.x · Cited by 460
Spencer, C. A., Takeuchi, M., Kazarosyan, M., Wang, C. C., Guttler, R. B., Singer, P. A., Fatemi, S., LoPresti, J. S., & Nicoloff, J. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4683 · Cited by 456
Kuhn, E., Wu, J., Karl, J., Liao, H., Zolg, W., & Guild, B. (2004) · PROTEOMICS · doi:10.1002/pmic.200300670 · Cited by 398
Spencer, C. A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1121 · Cited by 383
Hoofnagle, A. N., Becker, J. O., Wener, M. H., & Heinecke, J. W. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.109652 · Cited by 314 · cited 4×
“Incomplete digestion leads to variability in digestion from sample to sample, but despite this variability, multiple reports employing serum digestion and quantification by mass spectrometry have yielded promising results (Kuhn et al., 2004; Bondar et al., 2007; deWilde et al., 2008; Hoofnagle et al., 2008; Kuhn et al…”
BackgroundMethodInfluentialSelf-citationHortin, G. L., Sviridov, D., & Anderson, N. L. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108175 · Cited by 269
Kuhn, E., Addona, T., Keshishian, H., Burgess, M., Mani, D. R., Lee, R. T., Sabatine, M. S., Gerszten, R. E., & Carr, S. A. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.123935 · Cited by 247
Rotmensch, S., & Cole, L. A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)01324-6 · Cited by 243
Levinson, S. S., & Miller, J. J. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00275-9 · Cited by 236
Mass Spectrometry in the Clinical Laboratory
Chace, D. H. (2001) · Chemical Reviews · doi:10.1021/cr990077+ · Cited by 214
Phantoms in the Assay Tube: Heterophile Antibody Interferences in Serum Thyroglobulin Assays
Preissner, C. M., O’Kane, D. J., Singh, R. J., Morris, J. C., & Grebe, S. K. G. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030122 · Cited by 197
Investigation of an albumin‐enriched fraction of human serum and its albuminome
Gundry, R. L., Fu, Q., Jelinek, C. A., Van Eyk, J. E., & Cotter, R. J. (2007) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.200600276 · Cited by 194
Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research
Manley, S. E., Stratton, I. M., Clark, P. M., & Luzio, S. D. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077784 · Cited by 170
SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device
Anderson, N. L., Jackson, A., SMITH, D. S. H., Hardie, D. B., Borchers, C. H., & Pearson, T. W. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800446-mcp200 · Cited by 143
Prostate specific antigen: biology, biochemistry and available commercial assays
Ward, A. M., Catto, J. W. F., & Hamdy, F. C. (2001) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563011901055 · Cited by 136
Spencer, C. A., & LoPresti, J. S. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0757 · Cited by 135
von Mensdorff‐Pouilly, S., Gourevitch, M. M., Kenemans, P., Verstraeten, A. A., Litvinov, S. V., van Kamp, G. J., Meijer, S., Vermorken, J. B., & Hilgers, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00048-2 · Cited by 134
LC-MS/MS Quantification of Zn-α2 Glycoprotein: A Potential Serum Biomarker for Prostate Cancer
Bondar, O. P., Barnidge, D. R., Klee, E. W., Davis, B. J., & Klee, G. G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079681 · Cited by 123
Hennig, C., Rink, L., Fagin, U., Jabs, W. J., & Kirchner, H. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00206-9 · Cited by 117
Berna, M. J., Zhen, Y., Watson, D. E., Hale, J. E., & Ackermann, B. L. (2007) · Analytical Chemistry · doi:10.1021/ac070051f · Cited by 106
Proteomics strategies for protein identification
Resing, K. A., & Ahn, N. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.12.001 · Cited by 104
Performance Characteristics of Six Third-Generation Assays for Thyroid-Stimulating Hormone
Rawlins, M. L., & Roberts, W. L. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.039156 · Cited by 97
deWilde, A., Sadílková, K., Sadílek, M., Vasta, V., & Hahn, S. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.111989 · Cited by 96
The New Era of Automated Immunoassay
Bock, J. L. (2000) · American Journal of Clinical Pathology · doi:10.1309/dudm-3y6l-3r1l-qp15 · Cited by 91
Performance Characteristics of Seven Automated CA 125 Assays
Mongia, S. K., Rawlins, M. L., Owen, W. E., & Roberts, W. L. (2005) · American Journal of Clinical Pathology · doi:10.1309/nba3-12w0-lanr-xyh9 · Cited by 70
Humoral Response Profiling Reveals Pathways to Prostate Cancer Progression
Taylor, B. S., Pal, M. K., Yu, J., Laxman, B., Sundaram, S. K., Zhao, R., Menon, A., Wei, J. T., Nesvizhskii, A. I., Ghosh, D., et al. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700263-mcp200 · Cited by 66
Performance Characteristics of Five Automated CA 19-9 Assays
La’ulu, S. L., & Roberts, W. L. (2007) · American Journal of Clinical Pathology · doi:10.1309/h52vet3m6p7gywg1 · Cited by 63
Pettersson, K. S. I., Eriksson, S., Wittfooth, S., Engström, E., Nieminen, M. S., & Sinisalo, J. P. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115469 · Cited by 59
Cabaleiro, D. R., Uytfanghe, K. V., Stove, V. V., Fiers, T., & Thienpont, L. M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088393 · Cited by 54
Antibodies against biotinylated proteins are present in normal human serum.
Dale, G. L., Gaddy, P., & Pikul, F. J. (1994) · PubMed · Cited by 42
REINSBERG, J. (1996) · Clinical Biochemistry · doi:10.1016/0009-9120(95)02044-6 · Cited by 41
Biological and immunochemical characterization of recombinant human thyrotrophin
Canonne, C., Papandréou, M., MEDRI, G., Verrier, B., & Ronin, C. (1995) · Glycobiology · doi:10.1093/glycob/5.5.473 · Cited by 32
The Interference of Insulin Antibodies in Insulin Immunometric Assays
Sapin, R. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.121 · Cited by 28
Sapin, R., Agin, A., & Gasser, F. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.064 · Cited by 25
Kelly, L. S., Kozak, M., Walker, T. L., Pierce, M., & Puett, D. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.011 · Cited by 19
Anti-Thyrotropin Antibody Interference in Thyrotropin Assays
Sapin, R., d’Herbomez, M., Schlienger, J. L., & Wemeau, J. L. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2557 · Cited by 16
False-positive serum chromogranin A assay due to heterophile antibody interference
Giovanella, L., Ceriani, L., Lumastro, C., & Ghelfo, A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.001 · Cited by 14
Cited by
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Revisiting biomarker discovery by plasma proteomics
Geyer, P. E., Holdt, L. M., Teupser, D., & Mann, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20156297 · Cited by 917
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
Anderson, N. L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.126706 · Cited by 562
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
Uhlig, T., Kyprianou, T., Martinelli, F. G., Oppici, C. A., Heiligers, D., Hills, D., Calvo, X. R., & Verhaert, P. (2014) · EuPA Open Proteomics · doi:10.1016/j.euprot.2014.05.003 · Cited by 456
A targeted proteomics–based pipeline for verification of biomarkers in plasma
Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1900 · Cited by 364
Metadata
- Authors
- Hoofnagle, A. N., & Wener, M. H.
- Venue
- Journal of Immunological Methods
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 347
- Issue
- 1-2
- Pages
- 3-11
- ISSN
- 0022-1759 (ISSN-L)
- OpenAlex
- W2066322883
- Cited by
- 561
- References
- 46
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.